AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 155 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $253,000 | -44.6% | 111,800 | -29.6% | 0.00% | -60.0% |
| Q3 2021 | $457,000 | +113.6% | 158,800 | +181.6% | 0.01% | +150.0% |
| Q2 2021 | $214,000 | +35.4% | 56,400 | +20.5% | 0.00% | 0.0% |
| Q1 2021 | $158,000 | +177.2% | 46,800 | +129.4% | 0.00% | +100.0% |
| Q4 2020 | $57,000 | -78.7% | 20,400 | -80.8% | 0.00% | -66.7% |
| Q3 2020 | $267,000 | -82.4% | 106,500 | -4.7% | 0.00% | -83.3% |
| Q2 2020 | $1,518,000 | +31.2% | 111,800 | -26.8% | 0.02% | +12.5% |
| Q1 2020 | $1,157,000 | +1130.9% | 152,700 | +931.8% | 0.02% | +1500.0% |
| Q4 2019 | $94,000 | +6.8% | 14,800 | -34.2% | 0.00% | 0.0% |
| Q3 2019 | $88,000 | -33.8% | 22,500 | +38.9% | 0.00% | -50.0% |
| Q1 2019 | $133,000 | +75.0% | 16,200 | +18.2% | 0.00% | +100.0% |
| Q4 2018 | $76,000 | -94.6% | 13,700 | -90.3% | 0.00% | -94.1% |
| Q2 2018 | $1,408,000 | +283.7% | 141,100 | +266.5% | 0.02% | +325.0% |
| Q1 2018 | $367,000 | – | 38,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,100,000 | $15,004,000 | 2.10% |
| DAFNA Capital Management LLC | 830,538 | $4,020,000 | 1.51% |
| Baupost Group | 24,471,453 | $118,442,000 | 1.07% |
| Nantahala Capital Management | 5,789,561 | $28,021,000 | 0.86% |
| Old West Investment Management, LLC | 367,870 | $1,780,000 | 0.84% |
| Abrams Capital Management | 5,656,462 | $27,377,000 | 0.74% |
| Sofinnova Investments, Inc. | 848,356 | $4,106,000 | 0.38% |
| Stanley-Laman Group, Ltd. | 312,609 | $1,513,000 | 0.36% |
| Nantahala Capital Management | 2,000,000 | $9,680,000 | 0.30% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,494,070 | $7,231,000 | 0.24% |